Microbial transformation of albendazole

Indian Journal of Experimental Biology

Volumn 48, Issue 4, 2010, Pages 415-420

  Prasad, G Shyam ^a   Girisham, S ^a   Reddy, S M ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Albendazole; Albendazole sulfone; Albendazole sulfoxide; Biotransformation

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; DRUG DERIVATIVE;

ARTICLE; BIOTRANSFORMATION; GRAM NEGATIVE BACTERIUM; METABOLISM;

ALBENDAZOLE; ANTHELMINTICS; BIOTRANSFORMATION; GRAM-NEGATIVE BACTERIA;

ACTINOBACTERIA (CLASS); BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); ENTEROBACTER AEROGENES; ESCHERICHIA COLI; KLEBSIELLA AEROGENES; KLEBSIELLA PNEUMONIAE; MAMMALIA; PSEUDOMONAS AERUGINOSA; STREPTOMYCES GRISEUS;

EID: 77954289667     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gero A, Woodrow G & Walker J, Parasitic diseases today, here tomorrow? Today's Life Sci, July (1991)14
2. Smith J M, Parasitic infections. htpp://martinparasitology.mcgill.ca/incidence.htm. Accessed 26/10/2001.
3. Theodorides V J, Gyerik R J, Kingsbury W D & Parish R C, Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia, 32 (1976) 702.
4. Bogan J A & Marriner S E, Pharmacodynamic and toxicological aspects of albendazole in man and animals, in albendazole in helminthiasis, edited by Fock M (Royal Society of Medicine International Congress and Symposium, Series 61, London) 1984, 13.
5. Marriner S E, Morris D L, Dickson B & Bogan J A, Pharmacokinetics of albendazole in man, Eur J Clin Pharmacol, 30 (1986)705.
6. Hussar DA, New drugs of 1996, J Am Pharm Assoc, 37 (1997) 192.
7. Lanusse C, Virkel G, Sanchez S, Alvarez L, Lifschitz A, Imperiale F & Monfrinotlic A, Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves, Res Vet Sci, 65 (1998) 5.
8. Lanusse C E, Gascon L H & Prichard R K, Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: Relationship with plasma disposition kinetics, J Vet Pharmacol Ther,16 (1993) 38.
9. Smith L L, Steroids, in Biotechnology, Vol.6a, edited by H J Rehm and G Reed (Weinheim,Verlag Chemic GmbH), 1984, 31
10. Aleu J & Collado I S, Biotransformation by Botrytis species, J Mol Catal B, 13 (2001) 1377.
11. Holland H L, Chiral Sulfoxidation by Biotransformation of organic sulfides, Chem Rev, 88 (1988) 473.
12. Garcia J J, Bolas-Fernandez F & Torrado J J, Quantitative determination of albendazole and its main metabolites in plasma, J Chromatogr B,723 (1999)265.
13. Holland H L, Rand C G, Viski P & Brown F M, Microbial oxidation of benzyl sulfides and bibenzyl by Mortierella isabellina and Helminthosporium species, Can J Chem, 69 (1991) 1989.
14. Adam W, Frank H, Chantu R, Moller S, Taupp M, Meyer J M & Schreier P, Opposite enantioselectivities of two phenotypically and genotypically similar strains of Pseudomonas frederiksbergensis in bacterial whole-cell sulfoxidation, Appl. Environ. Microbiol, 71 (2005) 2199.
15. Gonzalo G, E, Marco 4-Hydroxyacetophenone monooxygenase from Pseudomonas fluorescens ACB as an oxidative biocatalyst in the synthesis of optically active sulfoxides, Tetrahedron: Asymmetry,17 (2006)130.
16. Feingersch R, Janna S, Thomas K W & Fishman A, Protein Engineering of Toluene Monooxygenases for Synthesis of Chiral Sulfoxides, Appl. Environ. Microbiol, 74 (2008) 1555.
17. Rawden H L, Kokwaro G O, Ward S A & Edwards G, Relative contribution of cytochromes P450 and flavin-containing monooxygenases to the metabolism of albendazole by human liver microsomes, Br J Clin Pharmacol, 49 (2000) 313.
18. ElAmri H, Mothe O, Totis M, Masson C, Batt A M, Delatour P & Siest G, Albendazole sulfonation by rat liver cytochrome P-450c, J Pharmacol Exp Ther, 246 (1988) 758.
19. White R E, McCarth M B, Egeberg K D & Sligar S G, Regioselectivity in the cytochromes p-450:Control by protein constraints and by chemical reactivities, Arch Biochem Biophys, 228 (1984) 493.
20. Smith R V & Rosazza J P, Microbial models for mammalian metabolism aromatic hydroxylation, Arch. Biochem. Biophys, 161 (1974) 551.
21. Rosazza J P, Kammer M, Youel L, Smith R.V, Erhardt P W, Truang D H & Leslie, S W, Microbial models for mammalian metabolism. O-Demethylation of papaverine. Xenobiotica. 7(1977) 133.
22. Chien M & Rosazza J P, Microbial transformations of natural antitumor agents. 15. Metabolism of bruceantin by Streptomyces griseus. J Chem. Soc Perkin Trans. 1 (1981) 1352.
23. Gyurik R J, Chow A W, Zaber B, Brunner E L, Miller J A, Villani A J, Petka L A & Parish R C, Metabolism of albendazole in cattle, sheep, rats and mice, Drug Metab Dispos, 9 (1981) 503.
24. Penicaut B, Maugein P, Maisonneuve H & Rossignol J F, Pharmacokinetics and urinary metabolism of albendazole in man, Bull Soc Pathol Exot Filiales, 76 (1983) 698.
25. El Amri H S, Fargetton X, Delatour P & Batt A M, Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes, Xenobiotica,17 (1987) 1159.
26. Benchaoui H A, Scott E W & McKellar Q A, Pharmacokinetics of albendazole, albendazole sulfoxide and netobimin in goats, J Vet Pharmacol Ther, 16 (1993) 237.
27. McKellar Q A, Jackson F, Coop R L & Baggot J D, Plasma profiles of albendazole metabolites after administration of netobimin and albendazole in sheep: Effects of parasitism and age, Br Vet J, 147 (1993)101.
28. Moroni P, Buronfosse T, Sauvageon C L Delatour P & Benoit E, Chiral sulfoxidation of albendazole by the flavin adenine dinucleotidecontaining and cytochrome P450-dependent monooxygenases from rat liver microsomes, Drug Metab Dispos, 23 (1995) 160.
29. Csiko G Y, Banhidi G Y, Semjen G, Laczay P, Vanyine Sandor G, Lehel J & Fekete, J, Metabolism and Pharmacokinetics of albendazole after oral administration to chickens, J Vet Pharmacol Ther,4 (1996)322.